pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Valbenazine
drug
save

valbenazine

Marketedupdated 3mo ago
by Lupin Ltd
Approved
community read0 votes

🐶 often sniffed alongside

top 5
  • tagApproval8 co-mentions · 4 sources
  • drugINGREZZA SPRINKLE6 co-mentions · 4 sources
  • tagSmall Molecule4 co-mentions · 4 sources
  • drugVALBENAZINE TOSYLATE4 co-mentions · 4 sources
  • companyZydus Lifesciences Ltd2 co-mentions · 2 sources

all catalysts(0)

nothing on the calendar yet

Trials studying valbenazine

  • phase4A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitorrecruitingn=50
  • phase2Valbenazine in Obsessive Compulsive Disordernot yet recruitingn=30
  • phase3Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsycompletedn=86
  • phase3Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canadaenrolling by invitationn=7
  • phase3Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophreniacompletedn=442
  • phase2Efficacy of Valbenazine for the Treatment of Trichotillomania in Adultsrecruitingn=20
  • phase4Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesiacompletedn=59
  • phase1Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazinewithdrawn
more trials →

News(0)

no news has mentioned this drug yet

brand
Valbenazine
generic
valbenazine
indication
Tardive Dyskinesia
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 26m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?